Logo image of ACHV

ACHIEVE LIFE SCIENCES INC (ACHV) Stock Fundamental Analysis

USA - NASDAQ:ACHV - US0044685008 - Common Stock

4.59 USD
-0.15 (-3.16%)
Last: 11/7/2025, 8:00:00 PM
4.5013 USD
-0.09 (-1.93%)
After Hours: 11/7/2025, 8:00:00 PM
Fundamental Rating

2

ACHV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. ACHV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ACHV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ACHV has reported negative net income.
ACHV had a negative operating cash flow in the past year.
In the past 5 years ACHV always reported negative net income.
ACHV had a negative operating cash flow in each of the past 5 years.
ACHV Yearly Net Income VS EBIT VS OCF VS FCFACHV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

With a Return On Assets value of -85.55%, ACHV is not doing good in the industry: 71.46% of the companies in the same industry are doing better.
ACHV has a Return On Equity of -121.00%. This is comparable to the rest of the industry: ACHV outperforms 41.60% of its industry peers.
Industry RankSector Rank
ROA -85.55%
ROE -121%
ROIC N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACHV Yearly ROA, ROE, ROICACHV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

ACHV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHV Yearly Profit, Operating, Gross MarginsACHV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

4

2. Health

2.1 Basic Checks

ACHV has more shares outstanding than it did 1 year ago.
ACHV has more shares outstanding than it did 5 years ago.
ACHV has a better debt/assets ratio than last year.
ACHV Yearly Shares OutstandingACHV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACHV Yearly Total Debt VS Total AssetsACHV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ACHV has an Altman-Z score of 0.84. This is a bad value and indicates that ACHV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ACHV (0.84) is better than 62.50% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that ACHV is not too dependend on debt financing.
ACHV has a Debt to Equity ratio of 0.21. This is in the lower half of the industry: ACHV underperforms 68.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACCN/A
WACCN/A
ACHV Yearly LT Debt VS Equity VS FCFACHV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

ACHV has a Current Ratio of 6.64. This indicates that ACHV is financially healthy and has no problem in meeting its short term obligations.
ACHV's Current ratio of 6.64 is fine compared to the rest of the industry. ACHV outperforms 67.16% of its industry peers.
A Quick Ratio of 6.64 indicates that ACHV has no problem at all paying its short term obligations.
ACHV has a Quick ratio of 6.64. This is in the better half of the industry: ACHV outperforms 67.54% of its industry peers.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 6.64
ACHV Yearly Current Assets VS Current LiabilitesACHV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

ACHV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.12%.
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ACHV will show a very strong growth in Earnings Per Share. The EPS will grow by 30.83% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.85%
EPS Next 2Y6.79%
EPS Next 3Y25.09%
EPS Next 5Y30.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACHV Yearly Revenue VS EstimatesACHV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2021 2022 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
ACHV Yearly EPS VS EstimatesACHV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1K -2K -3K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACHV. In the last year negative earnings were reported.
Also next year ACHV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACHV Price Earnings VS Forward Price EarningsACHV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACHV Per share dataACHV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

ACHV's earnings are expected to grow with 25.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.79%
EPS Next 3Y25.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACHV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACHIEVE LIFE SCIENCES INC

NASDAQ:ACHV (11/7/2025, 8:00:00 PM)

After market: 4.5013 -0.09 (-1.93%)

4.59

-0.15 (-3.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners61.44%
Inst Owner Change0.6%
Ins Owners4.07%
Ins Owner Change20.1%
Market Cap234.55M
Revenue(TTM)N/A
Net Income(TTM)-50.42M
Analysts83.08
Price Target15.64 (240.74%)
Short Float %9.77%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.25%
Min EPS beat(2)0.16%
Max EPS beat(2)0.34%
EPS beat(4)2
Avg EPS beat(4)-11.2%
Min EPS beat(4)-35%
Max EPS beat(4)0.34%
EPS beat(8)4
Avg EPS beat(8)-3.03%
EPS beat(12)6
Avg EPS beat(12)-0.93%
EPS beat(16)8
Avg EPS beat(16)-0.32%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.85%
EPS NY rev (1m)9.83%
EPS NY rev (3m)10.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.63
P/tB 5.9
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.06
Fwd EYN/A
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS0
BVpS0.82
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -85.55%
ROE -121%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.77%
ROA(5y)-100.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.64
Quick Ratio 6.64
Altman-Z 0.84
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y9.85%
EPS Next 2Y6.79%
EPS Next 3Y25.09%
EPS Next 5Y30.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-97.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.11%
OCF growth 3YN/A
OCF growth 5YN/A

ACHIEVE LIFE SCIENCES INC / ACHV FAQ

What is the fundamental rating for ACHV stock?

ChartMill assigns a fundamental rating of 2 / 10 to ACHV.


What is the valuation status for ACHV stock?

ChartMill assigns a valuation rating of 1 / 10 to ACHIEVE LIFE SCIENCES INC (ACHV). This can be considered as Overvalued.


What is the profitability of ACHV stock?

ACHIEVE LIFE SCIENCES INC (ACHV) has a profitability rating of 0 / 10.


Can you provide the financial health for ACHV stock?

The financial health rating of ACHIEVE LIFE SCIENCES INC (ACHV) is 4 / 10.


What is the earnings growth outlook for ACHIEVE LIFE SCIENCES INC?

The Earnings per Share (EPS) of ACHIEVE LIFE SCIENCES INC (ACHV) is expected to grow by 9.85% in the next year.